Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 2,217

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

The Global Burden of Cardiovascular Diseases and Risk

Open access
Vaduganathan, Muthiah, Mensah, George A., Turco, Justine Varieur, Fuster, Valentin, Roth, Gregory A.·2022·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2022.11.005
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2022.11.005

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 58

  1. Mensah, 2019, The global burden of cardiovascular diseases and risk factors: 2020 and beyond, J Am Coll Cardiol, 74, 2529, 10.1016/j.jacc.2019.10.009 · DOI · Paper page
  2. Roth, 2020, The global burden of cardiovascular diseases and risks: a compass for global action, J Am Coll Cardiol, 76, 2980, 10.1016/j.jacc.2020.11.021 · DOI · Paper page
  3. McGinnis, 1993, Actual causes of death in the United States, JAMA, 270, 2207, 10.1001/jama.1993.03510180077038 · DOI · Paper page
  4. Zheng, 2022, The Burden of Proof studies: assessing the evidence of risk, Nat Med, 28, 2038, 10.1038/s41591-022-01973-2 · DOI · Paper page
  5. Razo, 2022, Effects of elevated systolic blood pressure on ischemic heart disease: a Burden of Proof study, Nat Med, 28, 2056, 10.1038/s41591-022-01974-1 · DOI
  6. Wang, 2020, Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019, Lancet, 396, 1160, 10.1016/S0140-6736(20)30977-6 · DOI · Paper page
  7. Vaduganathan, 2020, Assessment of long-term benefit of intensive blood pressure control on residual life span: secondary analysis of the Systolic Blood Pressure Intervention Trial (SPRINT), JAMA Cardiol, 5, 576, 10.1001/jamacardio.2019.6192 · DOI
  8. Bress, 2017, Cost-effectiveness of intensive versus standard blood-pressure control, N Engl J Med, 377, 745, 10.1056/NEJMsa1616035 · DOI · Paper page
  9. Chow, 2021, Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial, Lancet, 398, 1043, 10.1016/S0140-6736(21)01922-X · DOI · Paper page
  10. Ferdinand, 2018, Novel interventions in addressing racial disparities in blood pressure control: potential utilization of barbershops in black men, Circulation, 138, 339, 10.1161/CIRCULATIONAHA.118.034869 · doi:10.1161/circulationaha.118.034869
  11. Victor, 2018, A cluster-randomized trial of blood-pressure reduction in black barbershops, N Engl J Med, 378, 1291, 10.1056/NEJMoa1717250 · DOI · Paper page
  12. Bryant, 2021, Cost-effectiveness of hypertension treatment by pharmacists in black barbershops, Circulation, 143, 2384, 10.1161/CIRCULATIONAHA.120.051683 · DOI
  13. Brownell, 2009, Ounces of prevention — the public policy case for taxes on sugared beverages, N Engl J Med, 360, 1805, 10.1056/NEJMp0902392 · DOI · Paper page
  14. Colchero, 2016, Beverage purchases from stores in Mexico under the excise tax on sugar sweetened beverages: observational study, BMJ, 352, h6704, 10.1136/bmj.h6704 · DOI · Paper page
  15. Colchero, 2017, In Mexico, evidence of sustained consumer response two years after implementing a sugar-sweetened beverage tax, Health Aff (Millwood), 36, 564, 10.1377/hlthaff.2016.1231 · DOI · Paper page
  16. Zhang, 2021, Association between cumulative low-density lipoprotein cholesterol exposure during young adulthood and middle age and risk of cardiovascular events, JAMA Cardiol, 6, 1406, 10.1001/jamacardio.2021.3508 · DOI · Paper page
  17. Braunwald, 2022, How to live to 100 before developing clinical coronary artery disease: a suggestion, Eur Heart J, 43, 249, 10.1093/eurheartj/ehab532 · DOI
  18. Braunwald, 2021, Cholesterol: the race to the bottom, Eur Heart J, 42, 4612, 10.1093/eurheartj/ehab446 · DOI
  19. Ray, 2022, Combination lipid-lowering therapy as first-line strategy in very high-risk patients, Eur Heart J, 43, 830, 10.1093/eurheartj/ehab718 · DOI · Paper page
  20. Musunuru, 2021, In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates, Nature, 593, 429, 10.1038/s41586-021-03534-y · DOI · Paper page
  21. Kohli-Lynch, 2019, Cost-effectiveness of low-density lipoprotein cholesterol level–guided statin treatment in patients with borderline cardiovascular risk, JAMA Cardiology, 4, 969, 10.1001/jamacardio.2019.2851 · DOI
  22. Zhang, 2021, Risk of cardiovascular hospital admission after exposure to fine particulate pollution, J Am Coll Cardiol, 78, 1015, 10.1016/j.jacc.2021.06.043 · DOI
  23. Al-Kindi, 2020, Environmental determinants of cardiovascular disease: lessons learned from air pollution, Nat Rev Cardiol, 17, 656, 10.1038/s41569-020-0371-2 · DOI · Paper page
  24. Bennett, 2019, Particulate matter air pollution and national and county life expectancy loss in the USA: a spatiotemporal analysis, PLoS Med, 16, 10.1371/journal.pmed.1002856 · DOI
  25. Owusu, 2020, Global estimation of mortality, disability-adjusted life years and welfare cost from exposure to ambient air pollution, Sci Total Environ, 742, 10.1016/j.scitotenv.2020.140636 · DOI
  26. Hammer, 2020, Global estimates and long-term trends of fine particulate matter concentrations (1998-2018), Environ Sci Technol, 54, 7879, 10.1021/acs.est.0c01764 · DOI · Paper page
  27. Rajagopalan, 2020, Personal-level protective actions against particulate matter air pollution exposure: a scientific statement from the American Heart Association, Circulation, 142, e411, 10.1161/CIR.0000000000000931 · DOI · Paper page
  28. Jagger, 2018, Implementation and scale-up of a biomass pellet and improved cookstove enterprise in Rwanda, Energy Sustain Dev, 46, 32, 10.1016/j.esd.2018.06.005 · DOI
  29. Venter, 2020, COVID-19 lockdowns cause global air pollution declines, Proc Natl Acad Sci U S A, 117, 18984, 10.1073/pnas.2006853117 · DOI · Paper page
  30. Jha, 2014, Global effects of smoking, of quitting, and of taxing tobacco, N Engl J Med, 370, 60, 10.1056/NEJMra1308383 · DOI · Paper page
  31. Wakefield, 2013, Introduction effects of the Australian plain packaging policy on adult smokers: a cross-sectional study, BMJ Open, 3, 10.1136/bmjopen-2013-003175 · DOI
  32. Lavie, 2018, Healthy weight and obesity prevention: JACC health promotion series, J Am Coll Cardiol, 72, 1506, 10.1016/j.jacc.2018.08.1037 · DOI · Paper page
  33. Pareek, 2018, Metabolic surgery: weight loss, diabetes, and beyond, J Am Coll Cardiol, 71, 670, 10.1016/j.jacc.2017.12.014 · DOI · Paper page
  34. Puska, 2020, The North Karelia Project: prevention of cardiovascular disease in Finland through population-based lifestyle interventions, Am J Lifestyle Med, 14, 495, 10.1177/1559827620910981 · DOI
  35. Lee, 2021, Effect of metformin and lifestyle interventions on mortality in the diabetes prevention program and diabetes prevention program outcomes study, Diabetes Care, 44, 2775, 10.2337/dc21-1046 · DOI
  36. Peñalvo, 2015, The SI! program for cardiovascular health promotion in early childhood: a cluster-randomized trial, J Am Coll Cardiol, 66, 1525, 10.1016/j.jacc.2015.08.014 · DOI
  37. Vaduganathan, 2015, Moving toward global primordial prevention in cardiovascular disease, J Am Coll Cardiol, 66, 1535, 10.1016/j.jacc.2015.08.027 · DOI
  38. McCoy, 2021, Second-line therapy for type 2 diabetes management: the treatment/benefit paradox of cardiovascular and kidney comorbidities, Diabetes Care, 44, 2302, 10.2337/dc20-2977 · DOI · Paper page
  39. Beran, 2018, Why are we failing to address the issue of access to insulin? A national and global perspective, Diabetes Care, 41, 1125, 10.2337/dc17-2123 · DOI
  40. 2021, Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis, Lancet Diabetes Endocrinol, 9, 825, 10.1016/S2213-8587(21)00240-0 · DOI
  41. Liyanage, 2015, Worldwide access to treatment for end-stage kidney disease: a systematic review, Lancet, 385, 1975, 10.1016/S0140-6736(14)61601-9 · DOI · Paper page
  42. Boersma, 2010, Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands, Clin Ther, 32, 1103, 10.1016/j.clinthera.2010.06.013 · DOI
  43. Johnson, 2019, Chronic kidney disease of unknown cause in agricultural communities, N Engl J Med, 380, 1843, 10.1056/NEJMra1813869 · DOI · Paper page
  44. Landrigan, 2018, The Lancet Commission on pollution and health, Lancet, 391, 462, 10.1016/S0140-6736(17)32345-0 · DOI · Paper page
  45. Brown, 2020, Developing a health impact model for adult lead exposure and cardiovascular disease mortality, Environ Health Perspect, 128, 10.1289/EHP6552 · DOI
  46. He, 2018, Low-level lead exposure and cardiovascular disease: the roles of telomere shortening and lipid disturbance, J Toxicol Sci, 43, 623, 10.2131/jts.43.623 · doi:10.2131/jts.43.623
  47. Lanphear, 2018, Low-level lead exposure and mortality in US adults: a population-based cohort study, Lancet Public Health, 3, e177, 10.1016/S2468-2667(18)30025-2 · DOI · Paper page
  48. Gasparrini, 2015, Mortality risk attributable to high and low ambient temperature: a multicountry observational study, Lancet, 386, 369, 10.1016/S0140-6736(14)62114-0 · DOI · Paper page
  49. Zhao, 2021, Global, regional, and national burden of mortality associated with non-optimal ambient temperatures from 2000 to 2019: a three-stage modelling study, Lancet Planet Health, 5, e415, 10.1016/S2542-5196(21)00081-4 · DOI · Paper page
  50. Anderson, 2009, Weather-related mortality: how heat, cold, and heat waves affect mortality in the United States, Epidemiology, 20, 205, 10.1097/EDE.0b013e318190ee08 · DOI · Paper page
  51. Allen, 2020, Implementation of non-communicable disease policies: a geopolitical analysis of 151 countries, Lancet Glob Health, 8, e50, 10.1016/S2214-109X(19)30446-2 · DOI
  52. Nishiga, 2020, COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives, Nat Rev Cardiol, 17, 543, 10.1038/s41569-020-0413-9 · DOI · Paper page
  53. Modin, 2020, Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction, Circulation, 142, 2080, 10.1161/CIRCULATIONAHA.120.050809 · DOI · Paper page
  54. Bhatt, 2020, Fewer hospitalizations for acute cardiovascular conditions during the COVID-19 pandemic, J Am Coll Cardiol, 76, 280, 10.1016/j.jacc.2020.05.038 · DOI · Paper page
  55. Patel, 2021, Diabetes care and glycemic control during the COVID-19 pandemic in the United States, JAMA Intern Med, 181, 1412, 10.1001/jamainternmed.2021.3047 · DOI
  56. Gumuser, 2021, Trends in cholesterol testing during the COVID-19 pandemic, Am J Prev Cardiol, 6, 10.1016/j.ajpc.2021.100152 · DOI
  57. Wadhera, 2021, Cardiovascular deaths during the COVID-19 pandemic in the United States, J Am Coll Cardiol, 77, 159, 10.1016/j.jacc.2020.10.055 · DOI · Paper page
  58. Roth, 2022, Impact of the COVID-19 pandemic on cardiovascular health in 2020: JACC state-of-the-art review, J Am Coll Cardiol, 80, 631, 10.1016/j.jacc.2022.06.008 · DOI · Paper page

Cited by

See all 2,217

Metadata

Authors
Vaduganathan, M., Mensah, G. A., Turco, J. V., Fuster, V., & Roth, G. A.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2022-12
Volume
80
Issue
25
Pages
2361-2371
ISSN
0735-1097 (ISSN-L)
DOI
10.1016/j.jacc.2022.11.005
OpenAlex
W4308559981
Cited by
2,217
References
19
FWCI
269.57
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Global Burden of Cardiovascular Diseases and Risk. https://app.cochat.ai/papers/10.1016/j.jacc.2022.11.005
The paper
Vaduganathan, M., Mensah, G. A., Turco, J. V., Fuster, V., & Roth, G. A. (2022). The Global Burden of Cardiovascular Diseases and Risk. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2022.11.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.